3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Peritoneal Metastases From Gastric Cancer
1
Ovarian Neoplasms
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
Esophageal Squamous Cell Carcinoma
1
Epstein-Barr Virus Infections
1
Colorectal Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Adenoid Cystic
1
Breast Neoplasms
1
Adenocarcinoma
1
Interventions
pembrolizumab
2
Cisplatin
2
Carboplatin
2
tocilizumab
1
infigratinib
1
etoposide phosphate
1
avelumab
1
apatinib
1
antineoplaston AS 2-1
1
antineoplaston A10
1
Radiotherapy
1
Paclitaxel
1
Nelfinavir
1
Induction Chemotherapy
1
Immunohistochemistry
1
Ifosfamide
1
Fluorouracil
1
Fluorescent Antibody Technique
1
Flow Cytometry
1
Etoposide
1
Electroacupuncture
1
Dexamethasone
1
Biopsy
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Nasopharyngeal Neoplasms
×
apatinib
×
Clear all
NCT02874651
2022-01-11
ADVANCE
Sun Yat-sen University
Phase 2
Terminated
25 enrolled